Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Peng Ji
Observed names:
JI Peng,
Ji Peng,
P Ji,
P. Ji
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center
Observed institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center,
Shanghai Cancer Institute,
Shenzhen Chronic Disease Prevention Center
ORCID:
0000-0002-5733-0604
Observed ORCID:
0000-0002-5733-0604
OpenAlex ID:
A5101645216
Metabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic Targets
2020
·
Yue Gong
, Peng Ji
, et al.
·
Cell Metabolism
·
527
PDF
Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study
2017
·
Yue Gong
, Yi-Rong Liu
, et al.
·
Scientific Reports
·
287
PDF
Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapy
2022
·
Huai-liang Wu
, Yue Gong
, et al.
·
Journal of Hematology & Oncology
·
211
The Burden and Trends of Breast Cancer From 1990 to 2017 at the Global, Regional, and National Levels: Results From the Global Burden of Disease Study 2017
2020
·
Peng Ji
, Yue Gong
, et al.
·
Frontiers in Oncology
·
117
PDF
In vivo multidimensional CRISPR screens identify Lgals2 as an immunotherapy target in triple-negative breast cancer
2022
·
Peng Ji
, Yue Gong
, et al.
·
Science Advances
·
97
Incidence proportions and prognosis of breast cancer patients with bone metastases at initial diagnosis
2018
·
Yue Gong
, Jing Zhang
, et al.
·
Cancer Medicine
·
57
PDF
Association between socioeconomic factors at diagnosis and survival in breast cancer: A population‐based study
2020
·
Peng Ji
, Yue Gong
, et al.
·
Cancer Medicine
·
45
PDF
Targeting translation regulators improves cancer therapy
2020
·
Shi-Long Jiang
, Jun-Luan Mo
, et al.
·
Genomics
·
30
Modified lymph node ratio improves the prognostic predictive ability for breast cancer patients compared with other lymph node staging systems
2019
·
Ming-Liang Jin
, Yue Gong
, et al.
·
The Breast
·
22
Development and Validation of Nomograms for Predicting Overall and Breast Cancer–Specific Survival in Young Women with Breast Cancer: A Population-Based Study
2018
·
Yue Gong
, Peng Ji
, et al.
·
Translational Oncology
·
20
PDF
Value of CXCL8–CXCR1/2 axis in neoadjuvant chemotherapy for triple-negative breast cancer patients: a retrospective pilot study
2020
·
Ruo-Xi Wang
, Peng Ji
, et al.
·
Breast Cancer Research and Treatment
·
19
In vivo CRISPR screens identify RhoV as a pro‐metastasis factor of triple‐negative breast cancer
2023
·
Ming‐Liang Jin
, Yue Gong
, et al.
·
Cancer Science
·
14
PDF
DHDH-mediated D-xylose metabolism induces immune evasion in triple-negative breast cancer
2024
·
Huai-liang Wu
, Yue Gong
, et al.
·
Med
·
13
Precision treatment with artificial intelligence assisted subtyping enhances therapeutic efficacy in HR+/HER2− breast cancer: The LINUXtrial
2025
·
Lei Fan
, Wen-Juan Zhang
, et al.
·
Cancer Cell
·
9
AlncRNA HULC as an effective biomarker for surveillance of the outcome of cancer: A meta-analysis
2017
·
Xiaoliang Chen
, Jinbo Lin
, et al.
·
PLoS ONE
·
8
PDF
Anbenitamab plus albumin-bound docetaxel (nab-docetaxel) ± carboplatin (Cb) versus trastuzumab and pertuzumab plus docetaxel (THP) ± Cb as neoadjuvant therapy for HER2-positive early or locally advanced breast cancer: A randomized, open-label, multicenter, phase 3 trial.
2026
·
Zhi-Ming Shao
, Peng Ji
, et al.
·
Journal of Clinical Oncology
·
4
Circadian Rhythm Disruption in Triple‐Negative Breast Cancer: Molecular Insights and Treatment Strategies
2025
·
Li‐Hua He
, Xin‐Yi Sui
, et al.
·
Journal of Pineal Research
·
4
PDF
SDF-1 expression and tumor-infiltrating lymphocytes identify clinical subtypes of triple-negative breast cancer with different responses to neoadjuvant chemotherapy and survival
2022
·
Ruo-Xi Wang
, Peng Ji
, et al.
·
Frontiers in Immunology
·
4
PDF
A machine learning model revealed that exosome small RNAs may participate in the development of breast cancer through the chemokine signaling pathway
2024
·
Jun-luan Mo
, Xi Li
, et al.
·
BMC Cancer
·
3
PDF
Abstract P2-08-16: The burden and trends of breast cancer from 1990 to 2017 at the global, regional, and national level: Results from the global burden of disease study 2017
2020
·
Yue Gong
, Peng Ji
, et al.
·
Cancer Research
·
3
Integrative analysis of metabolic subtypes in triple-negative breast cancer reveals new therapeutic strategies
2019
·
Y. Gong
, P. Ji
, et al.
·
Annals of Oncology
·
3
PDF
[Role of PD-1/PD-L1 in microenvironment of breast cancer].
2019
·
P Ji
, Y Gong
, et al.
·
PubMed
·
3
Neoadjuvant Anbenitamab and HB1801 in ERBB2 -Positive Breast Cancer: A Phase 3 Randomized Clinical Trial
2026
·
Junjie Li
, Tong Liu
, et al.
·
JAMA Oncology
·
2
PDF
Precision neoadjuvant treatment with AI-assisted subtyping in HR+/HER2−breast cancer: A randomized, phase 2 trial FASCINATE-N
2026
·
Jun-Jie Li
, Lin-Xiaoxi Ma
, et al.
·
Cell Reports Medicine
·
1
Abstract PO1-14-06: Integrated analysis reveals the impact of obesity on triple-negative breast cancer
2024
·
Yue Gong
, Peng Ji
, et al.
·
Cancer Research
·
1
Show more works
View as search
Works count:
30
Citation count:
1,505
H-index:
13
I10-index:
13
Year
Topic
Type